Denmark: IO Biotech names Sullivan as new CFO

Copenhagen-headquartered and Nasdaq listed IO Biotech, a clinical-stage biopharmaceutical company, has appointed Amy Sullivan as its new CFO. Sullivan, who joins from TABA, has more than 25 years of experience raising capital and building and managing corporate biotechnology and life sciences brands. Prior to TABA, she was chief strategy officer for Euronext-listed Kiadis Pharma where…

You must be a HMI Subscriber to view this content.

Subscribe Now »